Lazard Asset Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $1.21M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $93K | Buy |
|
|||||
|
2024
Q1 | $127K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.21M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $65K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $101K | Sell |
|
|||||
|
2020
Q2 | $338K | Buy |
|
|||||
|
2020
Q1 | $41K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $988K | Hold |
|
|||||
|
2019
Q1 | $858K | Hold |
|
|||||
|
2018
Q4 | $517K | Hold |
|
|||||
|
2018
Q3 | $762K | Sell |
|
|||||
|
2018
Q2 | $1.88M | Buy |
|
|||||
|
2018
Q1 | $869K | Sell |
|
|||||
|
2017
Q4 | $1.49M | Sell |
|
|||||
|
2017
Q3 | $990K | Sell |
|
|||||
|
2017
Q2 | $2.03M | Sell |
|
|||||
|
2017
Q1 | $1.88M | Sell |
|
|||||
|
2016
Q4 | $2.92M | Sell |
|
|||||
|
2016
Q3 | $3.76M | Buy |
|
|||||
|
2016
Q2 | $1.73M | Hold |
|
|||||
|
2016
Q1 | $1.84M | Hold |
|
|||||
|
2015
Q4 | $3.34M | Sell |
|
|||||
|
2015
Q3 | $2.64M | Sell |
|
|||||
|
2015
Q2 | $4.65M | Buy |
|